Биологическая активность
Simeprevir, also known as TMC43, is a препарат for the treatment and cure of hepatitis C. In the United States, simeprevir is approved by the Food and препарат Administration for use in combination with peginterferon-alfa and ribavirin for hepatitis C and hepatitis B. Simeprevir has been approved in Japan for the treatment of chronic hepatitis C infection, genotype 1.
Оригинал на английском
Simeprevir, also known as TMC43, is a drug for the treatment and cure of hepatitis C. In the United States, simeprevir is approved by the Food and Drug Administration for use in combination with peginterferon-alfa and ribavirin for hepatitis C and hepatitis B. Simeprevir has been approved in Japan for the treatment of chronic hepatitis C infection, genotype 1.
Химические свойства
- CAS №
- 1241946-89-3
- Брутто-формула
- C₃₈H₄₆N₅NaO₇S₂
- Мол. масса
- 771.92 г/моль
- Синонимы
- TMC435; TMC 435; TMC435; Simeprevir; Olysio.
Безопасность и документация
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.